| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/16/2006 | US20060058309 Respiratory syncytial virus replication inhibitors |
| 03/16/2006 | US20060058306 Solubilized topoisomerase poison agents |
| 03/16/2006 | US20060058304 Azaindole kinase inhibitors |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/16/2006 | US20060058288 Severe sepsis preventive therapeutic agent |
| 03/16/2006 | US20060058284 Compounds such as tert-butyl 3-(3,4-dichlorophenyl)-3-[3-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-8-yl)propyl]pyrrolidine-1-carboxylate;useful in the inhibition of HIV replication, therapy and prophylaxis of an HIV infection, and in therapy of the resulting acquired immune deficiency syndrome (AIDS) |
| 03/16/2006 | US20060058279 Topical compositions comprising ascomycins |
| 03/16/2006 | US20060058273 A combination of a cephalosporin. prednisolone and a carrier to treat milk-producing animals having clinical mastis of the mammary gland; increased antiinflammatory efficiency without the immunosuppressive side effects; bovine mastitis; veterninary medicine |
| 03/16/2006 | US20060058267 Pharmaceutical compositions comprising a NOS inhibitor |
| 03/16/2006 | US20060058253 Methods to reprogram splice site selection in pre-messenger rnas |
| 03/16/2006 | US20060058252 Methods and materials for treating human papillomavirus infections |
| 03/16/2006 | US20060058251 Use of immunostimulatory nucleic acids containing unmethylated CpG dinucleotide sequences to treat viral infections; use with viral antigen in vaccine or without a viral antigen |
| 03/16/2006 | US20060057714 Vector |
| 03/16/2006 | US20060057700 Using glycosylated pilin as diagnostic indicator and preventative initation in treating pseudomonal infections; immunotherapy; glycosylated with the O-antigen; Pseudomonas aeruginosa; Escherichia coli |
| 03/16/2006 | US20060057668 Antimicrobial polypeptide and utilization thereof |
| 03/16/2006 | US20060057648 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 03/16/2006 | US20060057163 adjuvant compound chosen from the acrylic or methacrylic polymers and the copolymers of maleic anhydride and an alkenyl derivative especially with polyalkenyl ethers of sugars or polyalcohols; heterologus influenza protein |
| 03/16/2006 | US20060057117 Vascular endothelial growth factor 2 |
| 03/16/2006 | DE10394214T5 Methyl-B-Orcinolcarboxylat aus Flechten (Everniastrum cirrhatum) zur Verwendung für die Behandlung von Pilzinfektionen und Krebs Methyl-B-Orcinolcarboxylat from lichens (Everniastrum cirrhatum) for use in the treatment of fungal infections and cancer |
| 03/16/2006 | DE10394212T5 Verfahren zur Herstellung einer antibakteriellen und antioxidierenden Fraktion aus Sanddornsamen (Hippophae rhamnoides L.) A process for the production of an antibacterial and antioxidant fraction from seeds of Seabuckthorn (Hippophae rhamnoides L.) |
| 03/16/2006 | DE102004040014A1 New aureonitrile compounds useful as cytostatic agents, fungicides and antibiotics |
| 03/16/2006 | CA2578841A1 Inhibitors of the hiv integrase enzyme |
| 03/16/2006 | CA2565235A1 [3.2.0] heterocyclic compounds and methods of using the same |
| 03/15/2006 | EP1634953A2 Platelet-activating factor acethylhydrolase |
| 03/15/2006 | EP1634888A2 Synthesis of 2'-deoxy-L-nucleosides |
| 03/15/2006 | EP1634878A1 Coumarins compounds, the preparation and the use thereof |
| 03/15/2006 | EP1634601A2 Dietary supplement comprising soyabean, mushroom and mung bean |
| 03/15/2006 | EP1634600A1 Antiallergic composition |
| 03/15/2006 | EP1634594A1 Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators |
| 03/15/2006 | EP1634593A2 Hypoglycemics comprising organic zinc (II) complexes |
| 03/15/2006 | EP1634592A2 Hypoglycemics comprising organic zinc (II) complexes |
| 03/15/2006 | EP1634591A2 Hypoglycemics comprising organic zinc (II) complexes |
| 03/15/2006 | EP1634590A1 Coronavirus inactivating agent |
| 03/15/2006 | EP1634589A1 Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 03/15/2006 | EP1634499A1 Aqueous compositions for disinfection and/or sterilization |
| 03/15/2006 | EP1633872A2 Novel human protease inhibitor-like proteins and polynucleotides encoding the same |
| 03/15/2006 | EP1633871A1 Double-stranded nucleic acid |
| 03/15/2006 | EP1633785A2 Human monoclonal antibodies against bacillusanthracis protective antigen |
| 03/15/2006 | EP1633778A1 Poly-gamma-glutamic acid conjugates for eliciting immune responses directed against bacilli |
| 03/15/2006 | EP1633776A1 MODIFIED i BORDETELLA /i ADENYLATE CYCLASE COMPRISING OR LACKING CD11b/CD18 INTERACTION DOMAIN AND USES THEREOF |
| 03/15/2006 | EP1633766A2 Modified fluorinated nucleoside analogues |
| 03/15/2006 | EP1633759A1 Cross-linked glycopeptide - cephalosporin antibiotics |
| 03/15/2006 | EP1633735A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 03/15/2006 | EP1633724A1 Phthalazinone derivatives |
| 03/15/2006 | EP1633399A2 Recombinant antibodies and compositions and methods for making and using the same |
| 03/15/2006 | EP1633396A1 Cd20 binding molecules |
| 03/15/2006 | EP1633395A1 Functionally reconstituted viral membranes containing adjuvant |
| 03/15/2006 | EP1633380A2 Antimicrobial and anticancer lipopeptides |
| 03/15/2006 | EP1448566B1 Chemokine receptor antagonists and methods of use thereof |
| 03/15/2006 | EP1401435B1 Topical application of thiazolyl amides |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | EP1322156B1 Disinfectant |
| 03/15/2006 | EP1294893B1 Modification of hepatitis b core antigen |
| 03/15/2006 | EP1263426B1 Preparations for the non-traumatic excision of a nail |
| 03/15/2006 | EP1250130A4 Propofol formulation with enhanced microbial inhibition |
| 03/15/2006 | EP1233783B9 Hbv/hcv virus-like particle |
| 03/15/2006 | EP1162997B1 Staphylococcus antigen and vaccine |
| 03/15/2006 | EP1140958B1 Anti-(retro)viral conjugates of saccharides and acetamidino or guanidino compounds |
| 03/15/2006 | EP1063885B1 Xylitol compositions for treating upper respiratory conditions |
| 03/15/2006 | EP1044022B1 Compositions and methods for targeted delivery of factors |
| 03/15/2006 | EP1035863B1 An over-expressing homologous antigen vaccine and a method of making the same |
| 03/15/2006 | EP0956859B1 Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 03/15/2006 | EP0939590B1 Nucleic acids for use in gene therapy involving intestinal cell gene expression |
| 03/15/2006 | CN1747970A Antigen/antibody or ligand/receptor glycosylated specificity exchangers |
| 03/15/2006 | CN1747937A Pyrimidine derivatives for the prevention of HIV infection |
| 03/15/2006 | CN1747746A Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
| 03/15/2006 | CN1747733A Treatment of bacterial diseases of the respiratory organs by locally applying fluoroquinolones |
| 03/15/2006 | CN1746190A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1746189A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1746184A Trichosanthin mutant and coding gene thereof |
| 03/15/2006 | CN1746183A Coronavirus (SARS-CoV)B-cell antigen determinate cluster with extensive cross immune activity |
| 03/15/2006 | CN1746181A Coronavirus specific T-cellantigen determinate cluster |
| 03/15/2006 | CN1746172A Preparation of plurichari |
| 03/15/2006 | CN1745849A Human bivalent purified hydrophobia vaccine and its preparation |
| 03/15/2006 | CN1745847A Medicine composition and method for treating hepatitis with arginase |
| 03/15/2006 | CN1745842A Chinese medicine for treating acute and chronic hepatitis and hepatocirrhosis, its preparation thereof |
| 03/15/2006 | CN1745821A Chinese medicinal preparation for treating AIDS |
| 03/15/2006 | CN1745773A Compound Chinese medicine for treating cold |
| 03/15/2006 | CN1745762A Compound metrinidazole preparation and its making method thereof |
| 03/15/2006 | CN1745756A Use for treating AIDS from ginseng saponin |
| 03/15/2006 | CN1745755A Nucleotide analog composition and synthesis method |
| 03/15/2006 | CN1245512C Vaccines containing recombinant pilin against i cneisseria gonorrhoeae (or i cneisseria meningitidis) |
| 03/15/2006 | CN1245419C Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses |
| 03/15/2006 | CN1245418C Novel cynthetic antibiotic peptide and its preparing method and use |
| 03/15/2006 | CN1245408C Use of Maituolaicin |
| 03/15/2006 | CN1245398C Extraction technology of baicalein, medicinal composition and preparation technology of medicine |
| 03/15/2006 | CN1245390C Compound of multiple substituted uracil class, preparation method and usage |
| 03/15/2006 | CN1245387C Use of 5-oxy-aporphine alkaloids in making hepatitis virus inhibiting activity drug |
| 03/15/2006 | CN1245385C Indole and dihydroindole derivatives |
| 03/15/2006 | CN1245216C Stabilized liquid polypeptide-containing. pharmaceutical compositions |
| 03/15/2006 | CN1245215C Recombination high efficiency composite interferon used as hepatitis B surface antigen and e antigen inhibitor |
| 03/15/2006 | CN1245207C Modified technique for making zedoary turmeric oil and glucose injection |
| 03/15/2006 | CN1245197C Chinese medicine preparation for treating coronary heart disease and viral myocarditis |
| 03/15/2006 | CN1245195C Traditional Chinese medicine composition for treating SARS and preparation process thereof |
| 03/15/2006 | CN1245161C A method of modulating ion channel functional activity |
| 03/14/2006 | US7012149 Subjecting green tea extract to chromatography on macroporous polyacrylate, then eluting via solvent; for use in foods and supplements |
| 03/14/2006 | US7012129 Comprises tripeptide amides for inhibiting human immunodeficiency virus infection; solid phase synthesis |
| 03/14/2006 | US7012088 Indolone oxazolidinones and derivatives thereof |
| 03/14/2006 | US7012079 (5R)-5-ethyl-9,10,difluoro-5-hydroxy-12-(2-trimethylsilylethyl)-4,5,13,15-tetrahydro-1H,3H-oxepino[3',4':6,7]-indoloizino[1,2-b]quinoline-3,15-dione for treatment of colon cancer |
| 03/14/2006 | US7012077 Anticholesterol agents; antilipemic agents |